Use of GRAFIX◊ Membrane to help prevent new or recurrent DFUs

English
Español (ES-INT)
Portuguêses Brasil (PT-BR)
日本語

AUTHOR(S): DaVanzo J, et al. Adv Wound Care (2022)

27 June 2022

Wound healing,
Acute,
Chronic/Challenging,
Diabetic foot ulcers,
Non healing,
Infection,
Wound care

Download Evidence in focus: Likelihood of new or recurrent DFUs was significantly reduced with GRAFIX™ Membrane compared with other cellular- and tissue-based products in an analysis of Medicare claims

Download (PDF 97 KB)

Share
Download

2008 - 2022 Smith & Nephew Plc. ◊Trademark of Smith+Nephew Product information is for educational purposes only, and not all products or indications are licensed in every country.

Evidence in focus: Likelihood of new or recurrent DFUs was significantly reduced with GRAFIX™ Membrane compared with other cellular- and tissue-based products in an analysis of Medicare claims

AUTHOR(S): DaVanzo J, et al. Adv Wound Care (2022)

27 June 2022

Download Evidence in focus: Likelihood of new or recurrent DFUs was significantly reduced with GRAFIX™ Membrane compared with other cellular- and tissue-based products in an analysis of Medicare claims

Related resources & events